References
- Ahsberg K, Olsson H, Stael von Holstein C. Increased mortality in prostate carcinoma and smoking-related disease after parietal cell vagotomy: a long-term follow-up study. Scand J Gastroenterol 44, 947–951, 2009.
- Anderson PR, Hanlon AL, Patchefsky A, Al-Saleem T, Hanks GE. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy. Int J Radiat Oncol Biol Phys 41, 1087–1092, 1998.
- Armaiz-Pena GN, Cole SW, Lutgendorf SK, Sood AK. Neuroendocrine influences on cancer progression. Brain Behav Immun 30 Suppl, S19–25, 2013.
- Bauman J, McVary K. Autonomic nerve development contributes to prostate cancer progression. Asian J Androl 15, 713–714, 2013.
- Bayon Lara AM, Landa Garcia I, Alcalde Escribano J, Rodriguez Dapena S, Ortega Medina L, Balibrea Cantero JL. Colonic carcinogenesis in vagotomyzed rats. Rev Esp Enferm Dig 93, 576–586, 2001.
- Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3, 401–410, 2003.
- Bjelakovic G, Tasic T, Stamenkovic I, Stojkovic M, Katic V, Otasinovic M, Bjelakovic G. Biochemical, cytological and microbiological characteristics of the cirrhotic, malignant and “mixed” ascites. Arch Oncol 9, 95–101, 2001.
- Borovikova LV, Ivanova S, Nardi D, Zhang M, Yang H, Ombrellino M, Tracey KJ. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 85, 141–147, 2000.
- Calvani M, Pelon F, Comito G, Taddei ML, Moretti S, Innocenti S, Nassini R, Gerlini G, Borgognoni L, Bambi F, Giannoni E, Filippi L, Chiarugi P. Norepinephrine promotes tumor microenvironment reactivity through beta3-adrenoreceptors during melanoma progression. Oncotarget 6, 4615–4632, 2015.
- Cao L, During MJ. What is the brain-cancer connection? Annu Rev Neurosci 35, 331–345, 2012.
- Costelli P, Tessitore L, Batetta B, Mulas MF, Spano O, Pani P, Baccino FM, Dessi S. Alterations of lipid and cholesterol metabolism in cachectic tumor-bearing rats are prevented by insulin. J Nutr 129, 700–706, 1999.
- Croci DO, Zacarias Fluck MF, Rico MJ, Matar P, Rabinovich GA, Scharovsky OG. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother 56, 1687–1700, 2007.
- Ekbom A, Lundegardh G, McLaughlin JK, Nyren O. Relation of vagotomy to subsequent risk of lung cancer: population based cohort study. BMJ 316, 518–519, 1998.
- Entschladen F, Lang K, Drell TL, Joseph J, Zaenker KS. Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol Immunother 51, 467–482, 2002.
- Entschladen F, Palm D, Lang K, Drell TLt, Zaenker KS. Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. Med Hypotheses 67, 33–35, 2006.
- Erin N, Akdas Barkan G, Harms JF, Clawson GA. Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level. Regul Pept 151, 35–42, 2008.
- Erin N, Duymus O, Ozturk S, Demir N. Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis. Regul Pept 179, 101–108, 2012.
- Fisher SG, Davis F, Nelson R, Weber L, Haenszel W. Large bowel cancer following gastric surgery for benign disease: a cohort study. Am J Epidemiol 139, 684–692, 1994.
- Fujita M, Takami M, Usugane M, Nampei S, Taguchi T. Enhancement of gastric carcinogenesis in dogs given Nmethyl-N’-nitro-N-nitrosoguanidine following vagotomy. Cancer Res 39, 811–816, 1979.
- Gidron Y, Perry H, Glennie M. Does the vagus nerve inform the brain about preclinical tumours and modulate them? Lancet Oncol 6, 245–248, 2005.
- Giuntoli RL, 2nd, Webb TJ, Zoso A, Rogers O, Diaz-Montes TP, Bristow RE, Oelke M. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res 29, 2875–2884, 2009.
- Hillen F, Griffioen AW. Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev 26, 489–502, 2007.
- Holm-Nielsen P. Pathogenesis of ascites in peritoneal carcinomatosis. Acta Pathol Microbiol Scand 33, 10–21, 1953.
- Horvathova L, Tillinger A, Sivakova I, Mikova L, Mravec B, Bucova M. Chemical sympathectomy increases neutrophil-to-lymphocyte ratio in tumor-bearing rats but does not influence cancer progression. J Neuroimmunol 278, 255–261, 2015.
- Horvathova L, Padova A, Tillinger A, Osacka J, Bizik J, Mravec B. Sympathectomy reduces tumor weight and affects expression of tumor-related genes in melanoma tissue in the mouse. Stress 19, 528–534, 2016a.
- Horvathova L, Tillinger A, Padova A, Mravec B. Sympathectomized tumor-bearing mice survive longer but develop bigger melanomas. Endocrine Regulations 50, 207–214, 2016b.
- Chang A, Kim-Fuchs C, Le CP, Hollande F, Sloan EK. Neural Regulation of Pancreatic Cancer: A Novel Target for Intervention. Cancers (Basel) 7, 1292–1312, 2015.
- Jobling P, Pundavela J, Oliveira SM, Roselli S, Walker MM, Hondermarck H. Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression. Cancer Res 75, 1777–1781, 2015.
- Karimi K, Bienenstock J, Wang L, Forsythe P. The vagus nerve modulates CD4+ T cell activity. Brain Behav Immun 24, 316–323, 2010.
- Kruszewska B, Felten SY, Moynihan JA. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J Immunol 155, 4613–4620, 1995.
- Lackovicova L, Banovska L, Bundzikova J, Janega P, Bizik J, Kiss A, Mravec B. Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats. Neoplasma 58, 424–429, 2011.
- Lansdown A, Rees DA. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? Clin Endocrinol (Oxf) 77, 791–801, 2012.
- Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer 115, 3379–3391, 2009.
- Lundegardh G, Ekbom A, McLaughlin JK, Nyren O. Gastric cancer risk after vagotomy. Gut 35, 946–949, 1994.
- Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, Frenette PS. Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361, 2013.
- Mancino M, Ametller E, Gascon P, Almendro V. The neuronal influence on tumor progression. Biochim Biophys Acta 1816, 105–118, 2011.
- Marzabal M, Garcia-Martinez C, Comas J, Lopez-Soriano FJ, Argiles JM. A flow cytometric study of the rat Yoshida AH-130 ascites hepatoma. Cancer Lett 72, 169–173, 1993.
- Mayordomo C, Garcia-Recio S, Ametller E, Fernandez-Nogueira P, Pastor-Arroyo EM, Vinyals L, Casas I, Gascon P, Almendro V. Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2. J Cell Physiol 227, 1358–1366, 2012.
- Meltzer JC, Grimm PC, Greenberg AH, Nance DM. Enhanced immunohistochemical detection of autonomic nerve fibers, cytokines and inducible nitric oxide synthase by light and fluorescent microscopy in rat spleen. J Histochem Cytochem 45, 599–610, 1997.
- Mikova L, Horvathova L, Ondicova K, Tillinger A, Vannucci LE, Bizik J, Gidron Y, Mravec B. Ambiguous effect of signals transmitted by the vagus nerve on fibrosarcoma incidence and survival of tumor-bearing rats. Neurosci Lett 593, 90–94, 2015.
- Moody TW, Hill JM, Jensen RT. VIP as a trophic factor in the CNS and cancer cells. Peptides 24, 163–177, 2003.
- Moreno-Smith M, Lee SJ, Lu C, Nagaraja AS, He G, Rupaimoole R, Han HD, Jennings NB, Roh JW, Nishimura M, Kang Y, Allen JK, Armaiz GN, Matsuo K, Shahzad MM, Bottsford-Miller J, Langley RR, Cole SW, Lutgendorf SK, Siddik ZH, Sood AK. Biologic effects of dopamine on tumor vasculature in ovarian carcinoma. Neoplasia 15, 502–510, 2013.
- Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987–2007). Brain Behav Immun 21, 736–745, 2007.
- Olar A, He D, Florentin D, Ding Y, Ayala G. Biologic correlates and significance of axonogenesis in prostate cancer. Hum Pathol 45, 1358–1364, 2014.
- Oluwadara O, Giacomelli L, Brant X, Christensen R, Avezova R, Kossan G, Chiappelli F. The role of the microenvironment in tumor immune surveillance. Bioinformation 5, 285–290, 2010.
- Palm D, Entschladen F. Neoneurogenesis and the neuro-neoplastic synapse. Prog Exp Tumor Res 39, 91–98, 2007.
- Park SY, Kang JH, Jeong KJ, Lee J, Han JW, Choi WS, Kim YK, Kang J, Park CG, Lee HY. Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1alpha protein-dependent mechanism. Int J Cancer 128, 2306–2316, 2011.
- Pavlov VA, Tracey KJ. The cholinergic anti-inflammatory pathway. Brain Behav Immun 19, 493–499, 2005.
- Raju B, Haug SR, Ibrahim SO, Heyeraas KJ. Sympathectomy decreases size and invasiveness of tongue cancer in rats. Neuroscience 149, 715–725, 2007.
- Raju B, Hultstrom M, Haug SR, Ibrahim SO, Heyeraas KJ. Sympathectomy suppresses tumor growth and alters gene-expression profiles in rat tongue cancer. Eur J Oral Sci 117, 351–361, 2009.
- Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 8, 1104–1109, 1988.
- Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg 4, 87–95, 2012.
- Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983–985, 1983.
- Shang Y. Hormones and cancer. Cell Res 17, 277–279, 2007.
- Shi M, Liu D, Yang Z, Guo N. Central and peripheral nervous systems: master controllers in cancer metastasis. Cancer Metastasis Rev 32, 603–621, 2013.
- Siegler R, Koprowska I. Mechanism of an ascites tumor formation. Cancer Res 22, 12733, 1962.
- Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, Sood AK, Cole SW. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 70, 7042–7052, 2010.
- Soll C, Jang JH, Riener MO, Moritz W, Wild PJ, Graf R, Clavien PA. Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology 51, 1244–1254, 2010.
- Stanojevic Z, Rancic G, Radic S, Potic-Zecevic N, Dordevic B, Markovic M, Todorovska I. Pathogenesis of malignant ascites in ovarian cancer patients. Arch Oncol 12, 115–118, 2004.
- Sundar SS, Ganesan TS. Role of lymphangiogenesis in cancer. J Clin Oncol 25, 4298–4307, 2007.
- Tatsuta M, Yamamura H, Iishi H, Ichii M, Noguchi S, Baba M, Taniguchi H. Promotion by vagotomy of gastric carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res 45, 194–197, 1985.
- Tessitore L, Bonelli G, Cecchini G, Amenta JS, Baccino FM. Regulation of protein turnover versus growth state: ascites hepatoma as a model for studies both in the animal and in vitro. Arch Biochem Biophys 255, 372–384, 1987.
- Tracey KJ. The inflammatory reflex. Nature 420, 853–859, 2002.
- Voss MJ, Entschladen F. Tumor interactions with soluble factors and the nervous system. Cell Commun Signal 8, 21, 2010.
- Wang L, Li JG, Jia BH, Wu YB, Zhou Q, Du ZH. [Protective effects of electric stimulation of vagus nerve on acute lung injury in rat with sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 19, 593–595, 2007.
- Yoshida T. Contributions of the ascites hepatoma to the concept of malignancy of cancer. Ann N Y Acad Sci 63, 852–881, 1956.
- Zhao CM, Hayakawa Y, Kodama Y, Muthupalani S, Westphalen CB, Andersen GT, Flatberg A, Johannessen H, Friedman RA, Renz BW, Sandvik AK, Beisvag V, Tomita H, Hara A, Quante M, Li Z, Gershon MD, Kaneko K, Fox JG, Wang TC, Chen D. Denervation suppresses gastric tumorigenesis. Sci Transl Med 6, 250ra115, 2014.